Kamiya Mehla

3.2k total citations · 1 hit paper
27 papers, 1.6k citations indexed

About

Kamiya Mehla is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kamiya Mehla has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Kamiya Mehla's work include Cancer, Hypoxia, and Metabolism (13 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Kamiya Mehla is often cited by papers focused on Cancer, Hypoxia, and Metabolism (13 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Kamiya Mehla collaborates with scholars based in United States, India and China. Kamiya Mehla's co-authors include Pankaj K. Singh, Michael A. Hollingsworth, Nina V. Chaika, Ryan J. King, Vinee Purohit, Robert Powers, Fang Yu, Keith R. Johnson, Prakash Radhakrishnan and Teklab Gebregiworgis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemistry.

In The Last Decade

Kamiya Mehla

26 papers receiving 1.6k citations

Hit Papers

Metabolic Regulation of Macrophage Polarization in Cancer 2019 2026 2021 2023 2019 100 200 300 400

Peers

Kamiya Mehla
Mario I. Vega United States
Lijun Di China
Xisong Ke China
Hong Gao China
Feng Xie China
Mario I. Vega United States
Kamiya Mehla
Citations per year, relative to Kamiya Mehla Kamiya Mehla (= 1×) peers Mario I. Vega

Countries citing papers authored by Kamiya Mehla

Since Specialization
Citations

This map shows the geographic impact of Kamiya Mehla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamiya Mehla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamiya Mehla more than expected).

Fields of papers citing papers by Kamiya Mehla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamiya Mehla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamiya Mehla. The network helps show where Kamiya Mehla may publish in the future.

Co-authorship network of co-authors of Kamiya Mehla

This figure shows the co-authorship network connecting the top 25 collaborators of Kamiya Mehla. A scholar is included among the top collaborators of Kamiya Mehla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamiya Mehla. Kamiya Mehla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mullen, Nicholas J., Surendra K. Shukla, Ravi Thakur, et al.. (2023). DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. eLife. 12. 20 indexed citations
2.
Mehla, Kamiya & Michael A. Hollingsworth. (2021). Inflammatory and immune effects on tumor progression. Trends in Immunology. 43(2). 93–95. 5 indexed citations
3.
King, Ryan J., Pankaj K. Singh, & Kamiya Mehla. (2021). The cholesterol pathway: impact on immunity and cancer. Trends in Immunology. 43(1). 78–92. 119 indexed citations
4.
Singh, Pankaj K., et al.. (2020). Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenal. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(1). 188387–188387. 27 indexed citations
5.
Shukla, Surendra K., Kuldeep S. Attri, Enza Vernucci, et al.. (2020). Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Cancer Letters. 484. 29–39. 50 indexed citations
6.
Soni, Kruti S., Divya Thomas, Thomas C. Caffrey, et al.. (2019). A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer. Journal of Pharmacology and Experimental Therapeutics. 370(3). 894–901. 18 indexed citations
7.
Mehla, Kamiya & Pankaj K. Singh. (2019). Metabolic Regulation of Macrophage Polarization in Cancer. Trends in cancer. 5(12). 822–834. 424 indexed citations breakdown →
8.
Haney, Staci L., Michelle L. Varney, Yashpal S. Chhonker, et al.. (2019). Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma. Oncogene. 38(26). 5308–5320. 27 indexed citations
9.
Attri, Kuldeep S., Kamiya Mehla, & Pankaj K. Singh. (2018). Evaluation of Macrophage Polarization in Pancreatic Cancer Microenvironment Under Hypoxia. Methods in molecular biology. 1742. 265–276. 20 indexed citations
10.
Attri, Kuldeep S., Kamiya Mehla, Surendra K. Shukla, & Pankaj K. Singh. (2018). Microscale Gene Expression Analysis of Tumor-Associated Macrophages. Scientific Reports. 8(1). 2408–2408. 7 indexed citations
11.
Mehla, Kamiya, Jarrod R. Tremayne, James A. Grunkemeyer, et al.. (2017). Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors. Cancer Immunology Immunotherapy. 67(3). 445–457. 20 indexed citations
12.
Shukla, Surendra K., Teklab Gebregiworgis, Vinee Purohit, et al.. (2014). Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer & Metabolism. 2(1). 18–18. 188 indexed citations
13.
Mehla, Kamiya & Pankaj K. Singh. (2014). MUC1: A novel metabolic master regulator. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1845(2). 126–135. 76 indexed citations
14.
Mehla, Kamiya, Sakshi Balwani, Anurag Agrawal, & Balaram Ghosh. (2013). Ethyl gallate attenuates acute lung injury through Nrf2 signaling. Biochimie. 95(12). 2404–2414. 29 indexed citations
15.
Singh, Pankaj K., et al.. (2012). Exome Sequencing and Advances in Crop Improvement. Advances in genetics. 79. 87–121. 7 indexed citations
16.
Chaika, Nina V., Fang Yu, Vinee Purohit, et al.. (2012). Differential Expression of Metabolic Genes in Tumor and Stromal Components of Primary and Metastatic Loci in Pancreatic Adenocarcinoma. PLoS ONE. 7(3). e32996–e32996. 79 indexed citations
17.
Singh, Pankaj K., Randall E. Brand, & Kamiya Mehla. (2012). MicroRNAs in pancreatic cancer metabolism. Nature Reviews Gastroenterology & Hepatology. 9(6). 334–344. 47 indexed citations
18.
Mehla, Kamiya, Saurabh Chaudhary, Arun Kumar, et al.. (2011). Advances in DNA sequencing: Challenges and limitations of personal sequencing. African Journal of Agricultural Research. 6(6). 1277–1280.
19.
Mehla, Kamiya, Sakshi Balwani, Ankur Kulshreshtha, et al.. (2011). Ethyl gallate isolated from Pistacia integerrima Linn. inhibits cell adhesion molecules by blocking AP-1 transcription factor. Journal of Ethnopharmacology. 137(3). 1345–1352. 47 indexed citations
20.
Sharma, Mamta, Kamiya Mehla, Jyotsna Batra, & Balaram Ghosh. (2007). Association of a chromosome 1q21 locus in close proximity to a late cornified envelope-like proline-rich 1 (LELP1) gene with total serum IgE levels. Journal of Human Genetics. 52(4). 378–383. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026